New drug combination lengthened survival for some with lung cancer
A study conducted under the Lung Cancer Master Protocol (Lung-MAP) found that patients with advanced non-small cell lung cancer whose cancer had progressed on previous immunotherapy lived significantly longer when treated ...
Jun 3, 2022
0
44